<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02167763</url>
  </required_header>
  <id_info>
    <org_study_id>CM2010.01</org_study_id>
    <nct_id>NCT02167763</nct_id>
  </id_info>
  <brief_title>Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD</brief_title>
  <official_title>Study of the VeraCept Intrauterine Device for Long Acting Reversible Contraception</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ContraMed LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ContraMed LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of the VeraCept Low
      Dose Intrauterine Copper Contraceptive compared to the standard T shaped copper IUD, the
      TCu380.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, subject-blinded, two arm controlled study of the Safety,
      Feasibility and Effectiveness of the VeraCept low-dose intrauterine copper contraceptive as
      compared to a concurrently controlled, commercially available standard copper &quot;T&quot; IUD
      (TCu380).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contraceptive Effectiveness</measure>
    <time_frame>12 Months</time_frame>
    <description>Number of subjects who become pregnant during the study period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Placement Feasibility</measure>
    <time_frame>At Enrollment</time_frame>
    <description>Ability of the clinician to successfully place the device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device Expulsion</measure>
    <time_frame>12 Months</time_frame>
    <description>Number of subjects identified with partially or fully expelled devices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability</measure>
    <time_frame>12 Months</time_frame>
    <description>Number of subjects who request device removal due to inability to tolerate the intervention (device)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at Insertion</measure>
    <time_frame>At Enrollment</time_frame>
    <description>Subject reported pain scores at device insertion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Prevention of Pregnancy</condition>
  <arm_group>
    <arm_group_label>VeraCept Intrauterine Contraceptive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The VeraCept low-dose Intrauterine Copper Contraceptive</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCu380</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A commercial standard T-shaped copper IUD (TCu380)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VeraCept Intrauterine Copper Contraceptive</intervention_name>
    <arm_group_label>VeraCept Intrauterine Contraceptive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TCu380 IUD</intervention_name>
    <arm_group_label>TCu380</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult females ages 18 to 42 (pre-menopausal)

          -  Have had at least one child (parous) and currently seeking long acting reversible
             contraception

          -  Normal uterine cavity as determined by ultrasound

          -  Willing to sign informed consent

          -  Able and willing to comply with study assessment schedule

        Exclusion Criteria:

          -  Post menopausal

          -  Pregnant (at time of enrollment)

          -  Known anatomical abnormalities of uterus, cervix and/or fallopian tubes

          -  Diagnosed or in treatment for cancer

          -  Untreated acute cervicitis

          -  In treatment for active Pelvic Inflammatory Disease

          -  Unexplained uterine bleeding or menometrorrhagia

          -  Known allergy to copper (Wilson's Disease) or imaging contrast media

          -  Unsuitable for study participation in the opinion of the Principal Investigator
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan M. Canela, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Canela</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinica Canela</name>
      <address>
        <city>La Romana</city>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Dominican Republic</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2014</study_first_submitted>
  <study_first_submitted_qc>June 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2014</study_first_posted>
  <last_update_submitted>January 26, 2017</last_update_submitted>
  <last_update_submitted_qc>January 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>contraception</keyword>
  <keyword>IUD</keyword>
  <keyword>copper</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Copper</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

